PEOPLE - Percardia (US) makes appointment:
This article was originally published in Clinica
Early stage medical device company Percardia (Merrimack, New Hampshire) has named Richard Popp as a member of the board. Percardia develops products aimed at treating coronary artery disease. Dr Popp is currently Professor of Medicine at Stanford University.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.